Fukuko Moriya

788 total citations
34 papers, 583 citations indexed

About

Fukuko Moriya is a scholar working on Immunology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Fukuko Moriya has authored 34 papers receiving a total of 583 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Immunology, 14 papers in Oncology and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Fukuko Moriya's work include Immunotherapy and Immune Responses (17 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Renal cell carcinoma treatment (6 papers). Fukuko Moriya is often cited by papers focused on Immunotherapy and Immune Responses (17 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Renal cell carcinoma treatment (6 papers). Fukuko Moriya collaborates with scholars based in Japan, United States and France. Fukuko Moriya's co-authors include Masanori Noguchi, Kyogo Itoh, Akira Yamada, Shigetaka Suekane, Kei Matsuoka, Satoko Matsueda, Tetsuro Sasada, Tatsuyuki Kakuma, Hirohisa Yano and Jun Akiba and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Clinical Cancer Research.

In The Last Decade

Fukuko Moriya

30 papers receiving 581 citations

Peers

Countries citing papers authored by Fukuko Moriya

Since Specialization

Citations

This map shows the geographic impact of Fukuko Moriya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fukuko Moriya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fukuko Moriya more than expected).

Fields of papers citing papers by Fukuko Moriya

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fukuko Moriya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fukuko Moriya. The network helps show where Fukuko Moriya may publish in the future.

Co-authorship network of co-authors of Fukuko Moriya

This figure shows the co-authorship network connecting the top 25 collaborators of Fukuko Moriya. A scholar is included among the top collaborators of Fukuko Moriya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fukuko Moriya. Fukuko Moriya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Relationship between job stress by effort-reward imbalance and work-related and medical accidents among medical professionals at university hospitals in Japan 2023 ·Mariko Nishikitani, (unknown), Hiroyuki Sawatari, Mizuho A. Kido, Fukuko Moriya, (unknown), Sawa Yasumoto, (unknown), (unknown), Kinuko Nagayoshi, Kiyoko Kato, Naoki Nakashima, Akiko Chishaki	0
2	Correlation Between Work Motivation and Life Events in Female Physicians 2021 ·The Kurume Medical Journal ·Fukuko Moriya, (unknown), (unknown), (unknown), Megumi Hara, (unknown), Takuji Torimura, Mizuho A. Kido, Hirohisa Yano	1
3	A randomized phase II clinical trial of personalized peptide vaccination with metronomic low-dose cyclophosphamide in patients with metastatic castration-resistant prostate cancer 2016 ·Cancer Immunology Immunotherapy ·Masanori Noguchi, Fukuko Moriya, (unknown), Satoko Matsueda, Tetsuro Sasada, Akira Yamada, Tatsuyuki Kakuma, Kyogo Itoh	56
4	An Open-Label, Randomized Phase II Trial of Personalized Peptide Vaccination in Patients with Bladder Cancer that Progressed after Platinum-Based Chemotherapy 2015 ·Clinical Cancer Research ·Masanori Noguchi, Kazumasa Matsumoto, Hirotsugu Uemura, Gaku Arai, Masatoshi Eto, Seiji Naito, Chikara Οhyama, Yasutomo Nasu, Masatoshi Tanaka, Fukuko Moriya, Shigetaka Suekane, Satoko Matsueda, Nobukazu Komatsu, Tetsuro Sasada, Akira Yamada, Tatsuyuki Kakuma, Kyogo Itoh	49
5	Immunotherapy in Prostate Cancer: Challenges and Opportunities 2015 ·Immunotherapy ·Masanori Noguchi, (unknown), Fukuko Moriya, Kyogo Itoh	10
6	A useful treatment for patients with advanced mixed-type small cell neuroendocrine carcinoma of the prostate: A case report 2013 ·Oncology Letters ·(unknown), (unknown), (unknown), Fukuko Moriya, Makoto Nakiri, (unknown), Shigetaka Suekane, Kei Matsuoka	10
7	A phase II trial of personalized peptide vaccination in castration-resistant prostate cancer patients: prolongation of prostate-specific antigen doubling time 2013 ·BMC Cancer ·Masanori Noguchi, Fukuko Moriya, Shigetaka Suekane, (unknown), Satoko Matsueda, Tetsuro Sasada, Akira Yamada, Kyogo Itoh	16
8	Successful treatment of erythropoietin-producing advanced renal cell carcinoma after targeted therapy using sunitinib: Case report and review of the literature 2012 ·Molecular and Clinical Oncology ·Kosuke Ueda, Shigetaka Suekane, (unknown), Makoto Nakiri, Fukuko Moriya, (unknown), (unknown), Kei Matsuoka	3
9	Phase II study of personalized peptide vaccination for castration‐resistant prostate cancer patients who failed in docetaxel‐based chemotherapy 2011 ·The Prostate ·Masanori Noguchi, Fukuko Moriya, Shigetaka Suekane, Kei Matsuoka, Gaku Arai, Satoko Matsueda, Tetsuro Sasada, Akira Yamada, Kyogo Itoh	32
10	Gene expression profiles in peripheral blood as a biomarker in cancer patients receiving peptide vaccination 2011 ·Cancer ·Nobukazu Komatsu, Satoko Matsueda, Kousuke Tashiro, Tetsuya Ioji, Shigeki Shichijo, Masanori Noguchi, Akira Yamada, Atsushi Doi, Shigetaka Suekane, Fukuko Moriya, Kei Matsuoka, Satoru Kuhara, Kyogo Itoh, Tetsuro Sasada	32
11	Successful Treatment of T4 Renal Cell Carcinoma After a Neoadjuvant Targeted Therapy Using Sunitinib: Report of a Case 2011 ·The Kurume Medical Journal ·Kousuke Ueda, Masanori Noguchi, (unknown), Fukuko Moriya, (unknown), (unknown), (unknown), Kei Matsuoka	2
12	A β-tubulin 5-derived peptide induces cytotoxic T lymphocytes restricted to the HLA-A24 allele in prostate cancer patients 2010 ·Experimental and Therapeutic Medicine ·Nobukazu Komatsu, (unknown), Fukuko Moriya, Shigetaka Suekane, Masanori Noguchi, Satoru Todo, Kyogo Itoh, Shigeki Shichijo	1
13	Phase I clinical study of a personalized peptide vaccination available for six different human leukocyte antigen (HLA-A2, -A3, -A11, -A24, -A31 and -A33)-positive patients with advanced cancer 2010 ·Experimental and Therapeutic Medicine ·Akira Yamada, Masanori Noguchi, Nobukazu Komatsu, Shigetaka Suekane, Shigeru Yutani, Fukuko Moriya, Takashi Mine, (unknown), K. Kawano, Kyogo Itoh	5
14	A randomized phase II trial of personalized peptide vaccine plus low dose estramustine phosphate (EMP) versus standard dose EMP in patients with castration resistant prostate cancer 2010 ·Cancer Immunology Immunotherapy ·Masanori Noguchi, Tatsuyuki Kakuma, Hirotsugu Uemura, Yasutomo Nasu, Hiromi Kumon, (unknown), Fukuko Moriya, Shigetaka Suekane, Kei Matsuoka, Nobukazu Komatsu, Shigeki Shichijo, Akira Yamada, Kyogo Itoh	81
15	Dexamethasone did not suppress immune boosting by personalized peptide vaccination for advanced prostate cancer patients 2008 ·The Prostate ·(unknown), Kyogo Itoh, Nobukazu Komatsu, Yuichi Yamashita, T Shirakusa, Akira Yamada, Fukuko Moriya, (unknown), (unknown), Kei Matsuoka, Masanori Noguchi	15
16	Growth Inhibitory Effects of IFN- β on Human Liver Cancer Cells In Vitro and In Vivo 2007 ·Journal of Interferon & Cytokine Research ·Sachiko Ogasawara, Hirohisa Yano, Seiya Momosaki, Jun Akiba, Naoyo Nishida, Sakiko Kojiro, Fukuko Moriya, Hironori Ishizaki, (unknown), Masamichi Kojiro	15
17	Effects of IFN- α on α -Fetoprotein Expressions in Hepatocellular Carcinoma Cells 2007 ·Journal of Interferon & Cytokine Research ·Hirohisa Yano, Yuji Basaki, Shinji Oie, Sachiko Ogasawara, Seiya Momosaki, Jun Akiba, Naoyo Nishida, Sakiko Kojiro, Hironori Ishizaki, Fukuko Moriya, (unknown), Suguru Fukahori, Michihiko Kuwano, Masamichi Kojiro	5
18	[298] GROWTH INHIBITORY EFFECTS OF PEGYLATED INTERFERON-a2a ON HUMAN LIVER CANCER CELLS IN VITRO AND IN VIVO 2007 ·Journal of Hepatology ·Hirohisa Yano, Satoshi Ogasawara, Seiya Momosaki, Jun Akiba, (unknown), Sakiko Kojiro, Hironori Ishizaki, Fukuko Moriya, Masamichi Kojiro	0
19	Overexpression of themyctarget geneMina53in advanced renal cell carcinoma 2007 ·Pathology International ·Hironori Ishizaki, Hirohisa Yano, Makoto Tsuneoka, Sachiko Ogasawara, Jun Akiba, Naoyo Nishida, Sakiko Kojiro, Suguru Fukahori, Fukuko Moriya, Kei Matsuoka, Masamichi Kojiro	45
20	Growth inhibitory effects of interferon‐α subtypes vary according to human liver cancer cell lines 2006 ·Journal of Gastroenterology and Hepatology ·Hirohisa Yano, Yoshiaki Yanai, Seiya Momosaki, Sachiko Ogasawara, Jun Akiba, Sakiko Kojiro, Fukuko Moriya, Suguru Fukahori, Masashi Kurimoto, Masamichi Kojiro	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact